摘要
目的:针对甲基化CpG结合蛋白2在胃癌患者中的表达情况以及与胃癌细胞多药耐药性的具体关系作用加以分析。方法:本次研究共纳入67例均已经病理检查确诊的单纯胃癌患者作为样本,分析纳入患者甲基化CpG结合蛋白2的表达情况以及对胃癌细胞多药耐药性的关系进行统计学研究。结果:甲基化CpG结合蛋白2在胃癌组织中呈高表达,且表达水平与患者肿瘤分期以及肿瘤转移情况具有密切的相关关系,且在I、Ⅱ期患者中的表达水平远高于Ⅲ、Ⅳ期患者,统计分析显示P<0.05,差异具备统计学意义。结论:甲基化CpG结合蛋白2在胃癌患者中的表达率相对较低,且与患者病症分期存在有密切关联,同时更存在有对多药耐药性进行抑制的效果。
Objectivee To analyze the role of methylated CpG binding protein 2 in gastric cancer and its relationship with To analyze the role of methylated CpG binding protein 2 in gastric cancer and its relationship with multidrug resistance in gastric cancer. g resistance in gastric cancer. Methods Methods A total of 67 patients with pathologically diagnosed gastric cancer were enrolled in this study. The expression of CpG-Binding Protein 2 and multidrug resistance in gastric cancer patients were statistically analyzed. y analyzed. Results Results Methylated CpG-2 was overexpressed in gastric cancer tissues and its expression level was Methylated Cp 2 was overexpressed in gastric cancer tissues and its expression level was closely related to tumor stage and tumor metastasis. The expression level of methylated CpG-2 in patients with stage I and II was much higher than those in patients with stage III and IV, the statistical analysis showed that P<0.05, the difference was statistically significant. y significant. Conclusion Conclusion The expression level of CpG-Binding protein 2 in gastric cancer patients is relatively low, The expression level of Cp g protein 2 in gastric cancer patients is relatively low, which is closely related to the stage of the disease. Also has the effect of inhibiting multidrug resistance.
出处
《影像研究与医学应用》
2018年第12期25-27,共3页
Journal of Imaging Research and Medical Applications
基金
泰安市科技发展计划(引导计划)(201730338)
关键词
甲基化CpG结合蛋白2
胃癌
耐药性
Methylated CpG binding protein 2
Gastric cancer
Multidrug resistance in gastric cancer cells
